BioCentury
ARTICLE | Clinical News

Mezavant mesalamine regulatory update

May 9, 2011 7:00 AM UTC

In February, Health Canada approved an expanded label for Mezavant mesalazine from Shire to include the maintenance of remission of ulcerative colitis (UC). The 5-aminosalicylate (5-ASA) mesalamine us...